Health Condition 1: S423- Fracture of shaft of humerus Health Condition 2: S520- Fracture of upper end of ulna
Conditions
Interventions
Intervention1: Group I-Fentanyl group(Group F): 25 ml solution of
bupivacaine 0.3% and fentanyl at a dose of 1mcg/kg of body weight,total
volume made upto 30 ml.
Group II-Dexmedetomidine group(Group
Sponsors
JNMCH
Eligibility
Inclusion criteria
Inclusion criteria: 1)ASA I&II Patients of either sex. 2)Age between 15-60 yrs. 3)Weight 40-80kg. 4)Patients planned for elective upper limb surgery
Exclusion criteria
Exclusion criteria: 1)Patients with cardiovascular diseases like coronary artery disease, hypertension ,heart blocks etc. 2)Patients with disease like diabetes ,peripheral neuropathy, coagulopathy. 3)Infection at the site of block . 4)Patients with known allergy to local anaesthetic and patients on adrenoceptor agonist or antagonists.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effect of fentanyl and dexmedetomidine as an adjuant to bupivacaine on onset and duration of block and postoperative analgesia in ultrasound guided supraclavicular brachial plexus block. Timepoint: base line immediately after injection every 15 min till 2 hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To compare the haemodynamic changes â?? a) Heart Rate(HR) b)Blood Pressure(BP)-Systolic BP(SBP), Diastolic BP(DBP),Mean Arterial Pressure(MAP). c) Oxygen Saturation(Spo2) 2. To look for complication ,if anyTimepoint: 10 MONTHS | — |
Countries
India
Contacts
Public ContactSHAMSE ALAM
jnmch amu aligarh
Outcome results
None listed